Asset Allocation

As of December 31, 2025.
Type % Net
Cash 1.71%
Stock 6.57%
Bond 87.74%
Convertible 0.00%
Preferred 5.64%
Other -1.66%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 87.49%    % Emerging Markets: 0.01%    % Unidentified Markets: 12.50%

Americas 83.77%
83.71%
Canada 2.88%
United States 80.82%
0.07%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 3.22%
United Kingdom 1.83%
1.38%
Austria 0.00%
France 0.01%
Germany 0.00%
Greece 0.46%
Ireland 0.10%
Netherlands 0.03%
Portugal 0.00%
Sweden 0.01%
Switzerland 0.75%
0.01%
Czech Republic 0.00%
Poland 0.01%
Turkey 0.00%
0.00%
Greater Asia 0.50%
Japan 0.02%
0.48%
Australia 0.48%
0.00%
Taiwan 0.00%
0.00%
Unidentified Region 12.50%

Bond Credit Quality Exposure

AAA 0.06%
AA 0.70%
A 3.91%
BBB 29.79%
BB 27.07%
B 14.24%
Below B 0.25%
    CCC 0.20%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.05%
Not Rated 17.04%
Not Available 6.94%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical --
Materials --
Consumer Discretionary --
Financials --
Real Estate --
Sensitive --
Communication Services --
Energy --
Industrials --
Information Technology --
Defensive --
Consumer Staples --
Health Care --
Utilities --
Not Classified --
Non Classified Equity --
Not Classified - Non Equity --
No Data Available
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 0.37%
Corporate 41.56%
Securitized 28.36%
Municipal 1.82%
Other 27.89%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
2.08%
Less than 1 Year
2.08%
Intermediate
39.57%
1 to 3 Years
14.86%
3 to 5 Years
14.78%
5 to 10 Years
9.94%
Long Term
48.64%
10 to 20 Years
20.23%
20 to 30 Years
19.58%
Over 30 Years
8.83%
Other
9.70%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial